NCT00940667View on ClinicalTrials.gov

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hypertension
Interventions
DRUG

Amlodipine plus Losartan

amlodipine/losartan 5/50mg q.d.

DRUG

Amlodipine

amlodipine 5mg q.d.

Trial Locations (1)

Unknown

13 sites in Korea, Seoul, Busan, Etc.

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT00940667 - Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter